GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Total Debt per Share

CAMRF (Camurus AB) Total Debt per Share : $0.03 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Total Debt per Share?

$0.03 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Camurus AB's Total Debt Per Share for the quarter that ended in Jun. 2024 was $0.03.


Camurus AB Total Debt per Share Historical Data

The historical data trend for Camurus AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Total Debt per Share Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.05 0.05 0.04

Camurus AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.04 0.04 0.04 0.03

Camurus AB Total Debt per Share Calculation

Camurus AB's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Camurus AB's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Camurus AB's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Q1 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Nine Months 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2022 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Camurus AB Special Call Transcript

By GuruFocus Research 03-02-2024

Q4 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q2 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2019 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024